DRIO
DarioHealth Corp. (NASDAQ)
Healthcare — Health Information Services
DarioHealth Corp. operates as a digital health company in the United States and internationally. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company offers Dario Connect, a solution used to create communities around specific health conditions to increase awareness and education; Dario Mind, a behavioral health offering that decreases the symptoms of stress, anxiety, and depression; Dario Move, focuses on improving posture to alleviate pain with medical device; and Dario Health, a self-care application and virtual coaching platform for diabetes, hypertension, and weight management and GLP-1. It also provides bundled full-suite or partial-suite subscriptions. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.
Price History
Fundamentals
| Market Cap | $49.36M |
| P/E Ratio (TTM) | - |
| Forward P/E | -9.93 |
| EPS (TTM) | $-8.50 |
| Dividend Yield | - |
| Profit Margin | -192.23% |
| Revenue Growth | -17.30% |
| ROE | -59.87% |
| Debt/Equity | 51.00 |
| Recommendation | None |
| Analyst Target | $18.50 |
| Analysts | 4 |
| Indexes | NASDAQ |
Technical Indicators
| RSI (14) | 42.4 |
| Beta | 1.08 |
| SMA 20 | - |
| SMA 40 | - |
| 52-Week High | $17.74 |
| 52-Week Low | $5.85 |
| 50-Day Avg | $7.44 |
| 200-Day Avg | $10.34 |
| Avg Volume | 11.8K |
| Volume | 10.3K |
Performance Analysis
NEUTRALDRIO presents a mixed picture with both positive and negative indicators.
Recent News
Last updated: Jul 02, 2026 13:06 UTC
Back to Screener Export Report